Cme Group Stock Price To Sales
| CHME34 Stock | BRL 331.99 6.48 1.99% |
CME Group fundamentals help investors to digest information that contributes to CME's financial success or failures. It also enables traders to predict the movement of CME Stock. The fundamental analysis module provides a way to measure CME's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CME stock.
CME |
CME Group Company Price To Sales Analysis
CME's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current CME Price To Sales | 69.07 X |
Most of CME's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CME Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, CME Group has a Price To Sales of 69 times. This is much higher than that of the Financial Services sector and significantly higher than that of the Financial Data & Stock Exchanges industry. The price to sales for all Brazil stocks is notably lower than that of the firm.
CME Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CME's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CME could also be used in its relative valuation, which is a method of valuing CME by comparing valuation metrics of similar companies.CME is currently under evaluation in price to sales category among its peers.
CME Fundamentals
| Return On Equity | 0.0992 | |||
| Return On Asset | 0.0102 | |||
| Profit Margin | 0.54 % | |||
| Operating Margin | 0.60 % | |||
| Current Valuation | 341.49 B | |||
| Shares Outstanding | 1.44 B | |||
| Price To Earning | 10.55 X | |||
| Price To Book | 2.27 X | |||
| Price To Sales | 69.07 X | |||
| Revenue | 5.02 B | |||
| Gross Profit | 5.02 B | |||
| EBITDA | 4.02 B | |||
| Net Income | 2.69 B | |||
| Cash And Equivalents | 1.19 B | |||
| Cash Per Share | 3.32 X | |||
| Total Debt | 3.42 B | |||
| Debt To Equity | 0.15 % | |||
| Current Ratio | 1.02 X | |||
| Book Value Per Share | 18.72 X | |||
| Cash Flow From Operations | 2.4 B | |||
| Earnings Per Share | 9.62 X | |||
| Price To Earnings To Growth | 4.61 X | |||
| Number Of Employees | 37 | |||
| Beta | 0.41 | |||
| Market Capitalization | 347.39 B | |||
| Total Asset | 174.18 B | |||
| Z Score | 60.6 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 174.18 B | |||
| Last Dividend Paid | 4.0 |
About CME Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CME Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CME using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CME Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in CME Stock
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.